Search

everythinglearnresearchcommunity

for

Search:↓

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Patients often experience long-lasting changes to their hair after stem cell transplants.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Umbilical cord blood transplantation improved the boy's symptoms despite complications.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

Brentuximab may cause hair to regain color.

CMV infection increases the risk of GvHD after bone marrow transplants.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

The meeting covered new findings in children's skin conditions and treatments, including the benefits of super absorbent polymer diapers.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

Platelet lysate could be a valuable treatment for many diseases in regenerative medicine.

Skin problems can indicate different diseases inside the body.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Mesenchymal stem cells are effective and safe for treating various diseases in children.

A woman with Degos disease managed her condition for nine years with medications and had two healthy pregnancies, while a separate finding suggests a possible link between female pattern hair loss and high blood pressure.

New methods for growing skin cells can improve skin grafts by building blood vessels within them.

The hole technique is faster and effective for hair transplant site creation.

A single medium, PRIME AIRLIFT, supports better human hair follicle formation in grafts.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.